Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10495/9124
Título : Identification of a RAC/AKT-like gene in Leishmania parasites as a putative therapeutic target in leishmaniasis
Autor : Varela Miranda, Rubén Eduardo
Ochoa Deossa, Rodrigo Alonso
Muskus López, Carlos Enrique
Muro, Antonio
Mollinedo Garcia, Faustino
Palabras clave : Therapeutic use
Leishmaniasis
Trypanosoma
Fecha de publicación : 2017
Editorial : BioMed Central
Citación : Varela-M RE, Ochoa R, Muskus CE, Muro A, Mollinedo F. Identification of a RAC/AKT-like gene in Leishmania parasites as a putative therapeutic target in leishmaniasis. Parasit Vectors. 2017;10(458):1-10. DOI: 10.1186/s13071-017-2379-y
Abstract : Leishmaniasis is one of the world's most neglected diseases caused by at least 20 different species of the protozoan parasite Leishmania. Although new drugs have become recently available, current therapy for leishmaniasis is still unsatisfactory. A subgroup of serine/threonine protein kinases named as related to A and C protein kinases (RAC), or protein kinase B (PKB)/AKT, has been identified in several organisms including Trypanosoma cruzi parasites. PKB/AKT plays a critical role in mammalian cell signaling promoting cell survival and is a major drug target in cancer therapy. However, the role of protozoan parasitic PKB/AKT remains to be elucidated. RESULTS: We have found that anti-human AKT antibodies recognized a protein of about 57 kDa in Leishmania spp. parasites. Anti-human phospho-AKT(Thr308) antibodies identified a protein in extracts from Leishmania spp. that was upregulated following parasite exposure to stressful conditions, such as nutrient deprivation or heat shock. Incubation of AKT inhibitor X with Leishmania spp. promastigotes under stressful conditions or with Leishmania-infected macrophages led to parasite cell death. We have identified and cloned a novel gene from Leishmania donovani named Ld-RAC/AKT-like gene, encoding a 510-amino acid protein of approximately 57.6 kDa that shows a 26.5% identity with mammalian AKT1. Ld-RAC/AKT-like protein contains major mammalian PKB/AKT hallmarks, including the typical pleckstrin, protein kinase and AGC kinase domains. Unlike mammalian AKT that contains key phosphorylation sites at Thr308 and Ser473 in the activation loop and hydrophobic motif, respectively, Ld-RAC/AKT-like protein has a Thr residue in both motifs. By domain sequence comparison, we classified AKT proteins from different origins in four major subcategories that included different parasites. CONCLUSIONS: Our data suggest that Ld-RAC/AKT-like protein represents a Leishmania orthologue of mammalian AKT involved in parasite stress response and survival, and therefore could become a novel therapeutic and druggable target in leishmaniasis therapy. In addition, following comparative sequence analyses, we found the RAC/AKT-like proteins from Leishmania constitute a subgroup by themselves within a general AKT-like protein family
Grupo de INV. : Programa de Estudio y Control de Enfermedades Tropicales (PECET)
URI : http://hdl.handle.net/10495/9124
ISSN : 17563305E
Aparece en las colecciones: Instituto de Investigaciones Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
VarelaRuben_2017_IdentificationLeishmaniaParasites.pdfArtículo de Revista1,49 MBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons

 


Gestión de T.I. /Sistema de Bibliotecas / Universidad de Antioquia / Cl. 67 Nº 53 - 108 - Bloque 8 Conmutador: 219 51 51- 219 51 40 comunicacionessistemadebibliotecas@udea.edu.co Medellín - Colombia